0001127602-19-010077.txt : 20190305 0001127602-19-010077.hdr.sgml : 20190305 20190305191540 ACCESSION NUMBER: 0001127602-19-010077 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190301 FILED AS OF DATE: 20190305 DATE AS OF CHANGE: 20190305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Colleran David CENTRAL INDEX KEY: 0001646558 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33462 FILM NUMBER: 19660630 MAIL ADDRESS: STREET 1: 600 TECHNOLOGY PARK DRIVE STREET 2: SUITE 200 CITY: BILLERICA STATE: MA ZIP: 01821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INSULET CORP CENTRAL INDEX KEY: 0001145197 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-600-7000 MAIL ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2019-03-01 0001145197 INSULET CORP PODD 0001646558 Colleran David C/O INSULET CORPORATION 100 NAGOG PARK ACTON MA 01720 1 SVP, Secretary and GC Common Stock 2019-03-01 4 M 0 16639 30.98 A 47072 D Common Stock 2019-03-01 4 M 0 1166 29.26 A 48238 D Common Stock 2019-03-01 4 M 0 1422 46.22 A 49660 D Common Stock 2019-03-01 4 M 0 1748 74.50 A 51408 D Common Stock 2019-03-01 4 S 0 20975 94.6536 D 30433 D Employee Stock Option (Right to Buy) 30.98 2019-03-01 4 M 0 16639 0 D 2025-06-29 Common Stock 16639 11093 D Employee Stock Option (Right to Buy) 29.26 2019-03-01 4 M 0 1166 0 D 2026-02-24 Common Stock 1166 5831 D Employee Stock Option (Right to Buy) 46.22 2019-03-01 4 M 0 1422 0 D 2027-02-22 Common Stock 1422 5686 D Employee Stock Option (Right to Buy) 74.50 2019-03-01 4 M 0 1748 0 D 2028-02-14 Common Stock 1748 5247 D Includes 1,443 restricted stock units granted on February 22, 2017, which vest on February 22, 2020; and 1,790 restricted stock units granted on February 14, 2018, which vest as to one-half of the total units on February 14, 2020 and one-half of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $94.37 to $94.99. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. /s/ David Colleran 2019-03-05